The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Meir Wetzler

Leukemia Section

Department of Medicine

Roswell Park Cancer Institute

Elm and Carlton Streets



Name/email consistency: high



  • Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, USA. 2000 - 2011
  • Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York 14263, USA. 2007


  1. Omacetaxine as an anticancer therapeutic: what is old is new again. Wetzler, M., Segal, D. Curr. Pharm. Des. (2011) [Pubmed]
  2. Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia. Wetzler, M., Andrews, C., Ford, L.A., Tighe, S., Barcos, M., Sait, S.N., Block, A.W., Nowak, N.J., Baer, M.R., Wang, E.S., Baumann, H. Cancer (2011) [Pubmed]
  3. Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity. Ghoshal, S., Rao, I., Earp, J.C., Jusko, W.J., Wetzler, M. Cancer Chemother. Pharmacol. (2010) [Pubmed]
  4. Preface: acute lymphoblastic leukemia--quo vadis?. Wetzler, M., Stock, W. Hematol. Oncol. Clin. North Am. (2009) [Pubmed]
  5. Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107. Wetzler, M., Donohue, K.A., Odenike, O.M., Feldman, E.J., Hurd, D.D., Stone, R.M., Westerfelt, P., Bloomfield, C.D., Larson, R.A. Leuk. Lymphoma (2008) [Pubmed]
  6. Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Wetzler, M., Sanford, B.L., Kurtzberg, J., DeOliveira, D., Frankel, S.R., Powell, B.L., Kolitz, J.E., Bloomfield, C.D., Larson, R.A. Blood (2007) [Pubmed]
  7. Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling. Wetzler, M., Earp, J.C., Brady, M.T., Keng, M.K., Jusko, W.J. Clin. Cancer Res. (2007) [Pubmed]
  8. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation. Wetzler, M., Brady, M.T., Tracy, E., Li, Z.R., Donohue, K.A., O'Loughlin, K.L., Cheng, Y., Mortazavi, A., McDonald, A.A., Kunapuli, P., Wallace, P.K., Baer, M.R., Cowell, J.K., Baumann, H. Clin. Cancer Res. (2006) [Pubmed]
  9. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Wetzler, M., Dodge, R.K., Mrózek, K., Stewart, C.C., Carroll, A.J., Tantravahi, R., Vardiman, J.W., Larson, R.A., Bloomfield, C.D. Br. J. Haematol. (2004) [Pubmed]
  10. Cytogenetics in adult acute lymphocytic leukemia. Wetzler, M. Hematol. Oncol. Clin. North Am. (2000) [Pubmed]
WikiGenes - Universities